Pharmaceutical manufacturing company, Institute of Drug Technology (IDT) Australia, has announced via an ASX announcement, that it has been granted a Medicinal Cannabis Manufacturing Licence from the Department of Health. The licence will allow IDT to manufacture extracts and tinctures of cannabis and cannabis resin, as well as to package, transport, store, and supply. According … Continue reading IDT secures medicinal cannabis licence
After claiming the title as the national hub of medicinal cannabis, Victoria is now set to win the title for a global centre for medicinal opium poppies, as the state focuses on growing its pharmaceutical manufacturing sector. TPI Enterprise, Australia’s only locally owned medicinal poppy processing company, is expanding its production with support from the Victorian government, creating … Continue reading Victoria set to grow as a pharmaceutical hub
Pharmaceutical company Mayne Pharma has announced launching an $80-million, oral solid-dose commercial manufacturing facility in Greenville, North Carolina. Mayne Pharma’s new 126,000-square-foot (11,700 square-meter) facility more than quadruples the company’s capacity to manufacture oral solid-dose pharmaceutical products in the United States to over one billion doses. The new facility also introduces significant capacity to manufacture … Continue reading Mayne Pharma opens new $80m US manufacturing facility
Pharmaceutical manufacturers Cyclotek and Cyclopharm have entered an agreement with Macquarie University to advance the Australian molecular imaging sector. The research will also involve radiopharmaceutical manufacturer, PETTECH Solutions, which will sell its existing FDG business operations to the newly formed entity, Cyclotek NSW, and also grant access to its cyclotron facility at Lucas Heights. Cyclopharm will also … Continue reading NSW manufacturers unite to develop world-first PET diagnostics
The Australian Industry and Skills Committee (AISC) has introduced a new training package to ensure VET meets the needs of industry by having industry involved in training development. The AISC is advised by industry, and MTPConnect and pharmaceutical firm IDT Australia have been working with the AISC to develop the new pharma sector training package that … Continue reading AISC’s new training package for pharma manufacturing businesses
Hoffmann-Krippner has announced the availability of the EHEDG (European Hygienic Engineering and Design Group) certified hygienic mounting kit for PiL’s P53 Steel Head ultrasonic sensors. This new, off-the-shelf, hygienic sensor solution has been designed for the chemical, pharmaceutical and food and beverage industries – suitable for any manufacturing/assembly/bottling/packaging system that requires a clean and hygienic … Continue reading Sensor for chemical and pharmaceutical industries
Nowchem has opened its $450,000 redeveloped pharmaceutical manufacturing facility at the Flinders Industrial Estate in Shoalhaven. The redevelopment has created eight new ongoing jobs at the facility. According to Nowchem managing director John Lamont, the expansion will enable his company to increase its capacity by 40 per cent. New positions in the company will include … Continue reading NSW pharmaceutical manufacturer creates eight new jobs
The makers of Nurofen have been fined $1.7 million over the misleading claim that some of its products offered targeted pain relief. The ABC and others report that the Federal Court found the claims of “pain specific” products misleading. These all contained the same active ingredient – 342 mg of ibuprofen lysine – though were … Continue reading Nurofen maker slapped with $1.7 million in penalties for misleading claims
Protective clothing and condom maker Ansell has posted a 21 per cent fall in first half profit as a result of weakening economic conditions.
UK pharmaceutical company GlaxoSmithKline has opened a new pilot plant to trial a promising vaccine storage method developed by the company, an Australian university and Belgian researchers.
Siemens and GlaxoSmithKline, one of the world’s leading research-based
pharmaceutical and healthcare companies, have entered a global strategic
The acting CEO of drug manufacturer Novogen has announced a review into all the company’s operations including its pre-clinical trials.
Australia’s first cell therapy manufacturing centre is bridging the gap between cell research in the lab.
Australian biotech Novogen wants $30.5m from investors as it plans to enter a major growth phase and continues its successful cancer research.
Shares in drug manufacturer Novogen rose 40 per cent after the company announced the results of a successful cancer drug study.
META has announced a collaborative project involving Hospira, GlaxoSmithKline and CSL aiming to increase the effectiveness of manufacturing.
Industry minister Ian Macfarlane has inspected the progress at a line upgrade at Hospira’s Mulgrave plant.
Samsung had earlier claimed they manufacture biosimilars at half the cost of what Western drugmakers would have to charge.
A government committee has recommended that the companies who manufacture two drugs be forced into a “pay for performance” model.
The expiration of patents, industry restructuring and other factors will put a squeeze on the pharmaceutical industry, according to a new report.